Breast Cancer Trial, Recruiting NCT04767659 Sponsor: IRCCS San Raffaele Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT04767659
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who are 18 years of age or older
  • Women who have recently been diagnosed with breast cancer and are being considered for chemotherapy treatment given before surgery
  • Women who are willing to formally agree to take part in the trial by signing a consent form

Who may not be able to join:

  • Women who are currently pregnant or breastfeeding
  • Women who are unable or unwilling to sign a consent form agreeing to participate
  • Women who have previously had surgery on the same breast being studied
  • Women whose cancer has spread to other parts of the body
  • Women who have breast implants

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: PANIZZA, IRCCS San Raffaele

Phone: 02-26436310

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele
Registry
ClinicalTrials.gov
Start date
27 January 2020
Est. completion
30 August 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Optical monitoring of neoadjuvant chemotherapy in breast cancer patients; Prediction of pathological complete response to neoadjuvant chemotherapy using optical imaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov